<unk>  refers to a regimen consisting of fludarabine, cyclophosphamide and mitoxantrone used in the treatment of resistant or relapsed chronic lymphocytic leukaemia.
FMC regimen
IAC regimen
COPP regimen
IFL regimen
FMR regimen
CNOP regimen
FMC-R regimen
RVD regimen